Why It Matters

Radiation Detection Co. is making its first federal lobbying push at a pivotal moment for radiation safety policy. The company hired Holland & Knight LLP and lobbyist Elizabeth Leoty Craddock—who previously served as Senate Energy and Natural Resources Committee Staff Director—to advocate on radiation monitoring standards.

Two bills directly affect RDC’s business prospects. The Nuclear Medicine Clarification Act (H.R. 2541) would require expanded reporting of radiation incidents in medical settings, while the FORGOTTEN Veterans Act (S. 2220) mandates comprehensive occupational radiation tracking for military personnel—both creating significant new market opportunities.

By the Numbers

RDC initiated federal lobbying in 2025 with no prior advocacy history, employing a dual-firm strategy:

Lobbying Team Structure:

Craddock brings over eight years of congressional experience, including as Staff Director of the Senate Energy and Natural Resources Committee (April-September 2014), providing direct NRC oversight experience.

The Agenda

RDC is lobbying specifically on "educating policymakers on the need for radiation monitoring and concerns for changing Federal radiation monitoring levels." The company provides accredited dosimetry services and radiation monitoring badges for medical, industrial, and research settings.

The timing is strategic. The Nuclear Medicine Clarification Act of 2025 (H.R. 2541) would compel the NRC to update regulations establishing new reporting criteria for radiation doses from medical extravasation. The FORGOTTEN Veterans Act of 2025 (S. 2220) mandates expanded occupational radiation monitoring for military personnel.

Broader Context

Congress is reshaping radiation safety policy while the Trump administration has directed the Nuclear Regulatory Commission to reconsider decades-old radiation protection standards. This creates both regulatory uncertainty and market opportunity as medical facilities face new compliance requirements and military expansion of exposure documentation increases demand for occupational dosimetry services.

Senator Angus King (I-ME) has highlighted critical gaps in Radiation Safety Officer positions at federal facilities, demonstrating bipartisan congressional interest in monitoring infrastructure.

Between The Lines

The Nuclear Medicine Clarification Act is actively contested, with debate over whether radiopharmaceutical extravasations should trigger mandatory medical event reporting. Representatives Don Davis (D-NC), Morgan Griffith (R-VA), and Ben Cline (R-VA) are driving the legislation, with an NRC final rule expected in spring 2026.

Bipartisan attention centers on historical compensation through Radiation Exposure Compensation Act reauthorization and contemporary safety standards, with King specifically flagging VA hospital contract cancellations eliminating Radiation Safety Officers.

Competitive Landscape

The Health Physics Society is RDC’s primary competitor, actively lobbying on radiation standards and occupational protection with recent filings showing engagement directly aligned with RDC’s legislative focus, particularly on extravasation issues.

Kromek USA previously lobbied on radiation detection equipment but terminated this activity in Q1 2025, reducing competition in occupational dosimetry advocacy.

The Bottom Line

RDC’s entry into federal lobbying aligns with congressional efforts to expand occupational exposure tracking. Key legislation would directly increase demand for dosimetry services, while Craddock’s former Senate committee role provides crucial congressional access. However, the Trump administration’s push to weaken radiation protection standards creates a complex regulatory environment with both risks and opportunities for monitoring service providers.

Spot something wrong? Report an issue with this article